aibio.space Debt Desk
Convertible notes, term loans, venture debt, credit facilities, notes offerings, refinancings, amendments, extensions, waivers and note exchanges.
Sources: SEC filings and company press releases, with wires, trade press and court dockets used as leads and confirmed against a filing. The desk follows our editorial standards. 314 stories so far.
Latest stories
- Pelthos amends Horizon venture loan, funds Loans E to H and adds Loans I and J
- Repligen announces $1.0 billion private convertible notes transaction
- FOXO to buy Ludwig Enterprises preferred stock with majority voting power
- Altimmune draws $10.0 million third tranche from Hercules loan facility
- SANUWAVE gets JPMorgan waiver on fixed charge ratio, tightens limits
- VolitionRx prepays $500,000 on Lind note and defers two monthly payments
- West Pharmaceutical enters $750 million revolver and $200 million term loan
- China Resources Pharmaceutical issues RMB800 million third tranche of notes
- Glucotrack sells secured convertible notes and warrants, with Dawson James as placement agent
- Integra LifeSciences sells $450 million of 9.500% senior secured notes, refinances credit facility
- China Resources Pharmaceutical unit issues RMB900 million corporate bonds
- Clearmind Medicine to sell $2,000,000 of convertible notes for $1,800,000 in cash
- Profusa issues $769,230.77 secured convertible note to Ascent Partners
- OSR Health amends VXM01 license to allow up to $15,000,000 in convertible notes
- ADC Therapeutics agrees to $86.6 million PIPE and plans loan cut to $50.0 million
- CDT Equity gets $3,000,000 first tranche of $6,750,000 convertible note
- Integra LifeSciences prices $450,000,000 senior secured notes
- TuHURA Biosciences draws $650,000 more on Parkview credit line
- SS Innovations issues $21,025,000.00 secured convertible note
- Co-Diagnostics issues senior secured convertible note to J.J. Astor
- Co-Diagnostics takes up to $3.1 million in secured convertible loans
- Revolution Medicines borrows $250.0 million under Royalty Pharma loan
- X4 Pharmaceuticals replaces loan with up to $150 million K2 facility
- X4 Pharmaceuticals signs up to $150 million senior loan with K2 HealthVentures
- CERo agrees to sell operating unit to SRX Global
- FibroBiologics sells $1,200,000 convertible debenture to Peak One
- Vaxcyte offers $500,000,000 of 1.50% convertible notes due 2032
- Nuo Therapeutics receives $325,000 second funding under loan
- Rocket Pharmaceuticals secures credit facility of up to $150 million
- Rocket Pharmaceuticals secures credit facility of up to $150 million from Hercules
- Profusa amends Ascent Partners convertible note terms
- iTonic Holdings extends maturity of bank loan to March 2027
- Positron issues three promissory notes at 20% interest, with warrants
- Odyssey Health extends two note maturities to January 2027
- TELA Bio gets lender consent to pause revenue covenant test
- Glucotrack amends terms of senior secured convertible note
- Celularity sells $11.01 million of secured convertible notes in deal of up to $25.0 million
- Jazz Pharmaceuticals extends term loan to 2033, adds $273,310,355.18
- IQVIA issues $2,000,000,000 of 6.375% senior notes due 2034
- Viking Therapeutics sells $225,000,000 of 2.00% convertible notes due 2032
aibio